Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;28(6):1311-1326.
doi: 10.1038/s41593-025-01964-9. Epub 2025 May 26.

Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles

Affiliations

Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles

Sophie A Rogers et al. Nat Neurosci. 2025 Jun.

Abstract

The psychedelic drug psilocybin demonstrates rapid and long-lasting efficacy across neuropsychiatric disorders that are characterized by behavioral inflexibility. However, its impact on the neural activity underlying sustained changes in behavioral flexibility has not been characterized. To test whether psilocybin enhances behavioral flexibility by altering activity in cortical neural ensembles, we performed longitudinal single-cell calcium imaging in the mouse retrosplenial cortex across a 5-day trace fear learning and extinction assay. We found that a single dose of psilocybin altered cortical ensemble turnover and oppositely modulated fear- and extinction-active neurons. Suppression of fear-active neurons and recruitment of extinction-active neurons predicted psilocybin-enhanced fear extinction. In a computational model of this microcircuit, inhibition of simulated fear-active units modulated recruitment of extinction-active units and behavioral variability in freezing, aligning with experimental results. These results suggest that psilocybin enhances behavioral flexibility by recruiting new neuronal populations and suppressing fear-active populations in the retrosplenial cortex.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

Update of

Similar articles

Cited by

References

    1. Castaldelli-Maia, J. M. & Bhugra, D. Analysis of global prevalence of mental and substance use disorders within countries: focus on sociodemographic characteristics and income levels. Int. Rev. Psychiatry 34, 6–15 (2022). - PubMed - DOI
    1. Nutt, D. & Carhart-Harris, R. The current status of psychedelics in psychiatry. JAMA Psychiatry 78, 121–122 (2021). - PubMed - DOI
    1. Griffiths, R. R. et al. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology 218, 649–665 (2011). - PubMed - PMC - DOI
    1. Agin-Liebes, G. I. et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J. Psychopharmacol. 34, 155–166 (2020). - PubMed - DOI
    1. Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K., Davoli, C. C. & Davis, A. K. Long-term effects of psychedelic drugs: a systematic review. Neurosci. Biobehav. Rev. 113, 179–189 (2020). - PubMed - DOI

LinkOut - more resources